BioSpace News Archive

Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for FMX103

100% Accuracy in Detecting Zygosity Enables Earlier Risk Stratification for Serious Perinatal Complications

To ensure its valued customers receive the best service possible Visioneering Technologies Inc., announced that experienced sales executive Suzette Tineo has joined VTI as a Territory Manager to serve eye care professionals in the Los Angeles market.

Exo Imaging, Inc., a company pioneering a high-performance ultrasound platform based on patented Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology and artificial intelligence (AI) for imaging and therapeutic applications, announced a $35M Series B financing round.

UroGen Pharma Ltd. (Nasdaq:URGN) today announced that it will report second quarter 2019 financial results on Friday, August 9, 2019, prior to the open of the market.

Veltex Corporation – OTC Markets symbol (VLXC) Veltex Corporation (“Veltex”) announces the appointment of Luba Andrus, RPh., M.J. to the Board of Directors.

Accidentally dislodged breathing tube is fourth-most common adverse event in the nation’s NICUs [05-August-2019] WASHINGTON , Aug. 5, 2019 /PRNewswire/ -- A quality-improvement project at the neonatal intensive care unit (NICU) at Children’s National that included standardized taping methods, bedside review of events within 72 hours and reducing how often newborns r

Antidote Therapeutics, Inc., (ATI) announced today the publication of the successful protein engineering of proprietary variants of the nicotine-degrading enzyme, NicA2, for potential therapeutic use in smoking cessation and other nicotine addiction disorders.

Unconventional Wealth has little to do with Wall Street, or the market for that matter.

A group of 14 individuals will embark on this challenge to raise awareness for multiple myeloma